EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists

Samuele Maramai iD, Claudia Mugnaini, Marco Paolino iD, Aniello Schiano Moriello, Luciano De Petrocellis iD, Federico Corelli iD, Francesca Aiello iD, Antonella Brizzi iD

Molecules · 2025

DOI: 10.3390/molecules30030721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Samuele Maramai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. Hauptthemen laut MEDLINE: TRPV Cation Channels, Indoles, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Siena, Università di Siena, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to its central role in pain, inflammation, and related disorders, the Transient Receptor Potential (TPR) Vanilloid Type-1 (TRPV1) ion channel represents an attractive target for the development of novel antinociceptive and anti-inflammatory agents. Capsaicin, the natural component of chili peppers, is one of the most investigated agonists of this receptor. Several modifications of its structure have been attempted, aiming at finding TRPV1 agonists with improved characteristics, but, to date, no capsaicin-derived agents have reached the market. Based on our previous knowledge of the design and synthesis of TRPV1 agonists, in this paper we propose two small series of indole-2-carboxamides as novel and selective agonists for this ion channel. The newly developed compounds have been structurally characterized and tested in vitro for their ability to modulate TRPV1, in terms of efficacy, potency (EC50), and desensitization (IC50) properties. For the most promising derivatives, selectivity over the TRP ankyrin-1 (TRPA1) channel has been reported. From our study, compound 6g arose as a promising candidate for further evaluation, also in correlation with its in silico-predicted drug-like properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsIndolesDrug DesignHumansStructure-Activity RelationshipCapsaicinAnimalsMolecular StructureHEK293 Cells

Stichwörter der Autor:innen

TRPV1 agonistcapsaicinindole-2-carboxamidespain

Substanzen

TRPV Cation ChannelsIndolesTRPV1 protein, humanCapsaicin

Autor:innen und Institutionen

  • Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
  • Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
  • Epitech Group SpA, 35030 Saccolongo, Italy.
  • Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.

ORCID-Profile: Samuele Maramai, Marco Paolino, Luciano De Petrocellis, Federico Corelli, Francesca Aiello, Antonella Brizzi

Förderung

  • University of Siena
  • Università di Siena, Italy

Zitieren

APA

Maramai, S., Mugnaini, C., Paolino, M., Schiano Moriello, A., De Petrocellis, L., Corelli, F., Aiello, F., & Brizzi, A. (2025). Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists. Molecules. https://doi.org/10.3390/molecules30030721

Vancouver

Maramai S, Mugnaini C, Paolino M, Schiano Moriello A, De Petrocellis L, Corelli F, et al. Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists. Molecules. 2025. doi:10.3390/molecules30030721

BibTeX
@article{Maramai2025,
  author = {Maramai, Samuele and Mugnaini, Claudia and Paolino, Marco and Schiano Moriello, Aniello and De Petrocellis, Luciano and Corelli, Federico and Aiello, Francesca and Brizzi, Antonella},
  title = {Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30030721}
}
Kostenlos starten →